Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor
Min Sui,1,* Meimei Xiong,2,* Yuling Li,1,* Qiao Zhou,1 Xiaofei Shen,3 Da Jia,3 Maling Gou,2 Qingxiang Sun1 1Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, and Collaborative Innovation Centre for Biotherapy, Chengdu, 610041, People’s...
Guardado en:
Autores principales: | Sui M, Xiong M, Li Y, Zhou Q, Shen X, Jia D, Gou M, Sun Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aaf3cd405d214ad3a66a03f48ba6abd1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRODUCTION OF RECOMBINANT PROTEIN CRM197 IN ESCHERICHIA COLI
por: I. V. Dukhovlinov, et al.
Publicado: (2015) -
CRM AT THE HEART OF THE DIGITAL TRANSFORMATION
por: INTISSAR KARIM, et al.
Publicado: (2021) -
CRM System: the Role of Dynamic Capabilities in creating Innovation Capability
por: Cristiane Drebes Pedron, et al.
Publicado: (2018) -
Representing and Validating Cultural Heritage Knowledge Graphs in CIDOC-CRM Ontology
por: Ghazal Faraj, et al.
Publicado: (2021) -
Novel Peptide Therapeutic Approaches for Cancer Treatment
por: Caroline M. Li, et al.
Publicado: (2021)